Research ArticleAccepted Article
Anti-IL-6 Therapy Effect for Refractory Joint and Skin Involvement in Systemic Sclerosis: A Real-world, Single Center Experience
Stylianos T. Panopoulos, Maria G. Tektonidou, Vasiliki-Kalliopi Bournia, Aikaterini Arida and Petros P. Sfikakis
The Journal of Rheumatology August 2021, jrheum.210273; DOI: https://doi.org/10.3899/jrheum.210273
Stylianos T. Panopoulos
First Department of Propaedeutic and Internal Medicine and Joint Rheumatology Program, National and Kapodistrian University of Athens, Medical School, Athens, Greece. The source(s) of support in the form of grants or industrial support This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Address correspondence to Stylianos Panopoulos, MD, PhD, Joint Rheumatology Program, Rheumatology Unit, 1st Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens, Μedical School General Hospital of Athens LAIKO. 17 Agiou Thoma str., 115 27 Athens, Greece.
Maria G. Tektonidou
First Department of Propaedeutic and Internal Medicine and Joint Rheumatology Program, National and Kapodistrian University of Athens, Medical School, Athens, Greece. The source(s) of support in the form of grants or industrial support This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Address correspondence to Stylianos Panopoulos, MD, PhD, Joint Rheumatology Program, Rheumatology Unit, 1st Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens, Μedical School General Hospital of Athens LAIKO. 17 Agiou Thoma str., 115 27 Athens, Greece.
Vasiliki-Kalliopi Bournia
First Department of Propaedeutic and Internal Medicine and Joint Rheumatology Program, National and Kapodistrian University of Athens, Medical School, Athens, Greece. The source(s) of support in the form of grants or industrial support This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Address correspondence to Stylianos Panopoulos, MD, PhD, Joint Rheumatology Program, Rheumatology Unit, 1st Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens, Μedical School General Hospital of Athens LAIKO. 17 Agiou Thoma str., 115 27 Athens, Greece.
Aikaterini Arida
First Department of Propaedeutic and Internal Medicine and Joint Rheumatology Program, National and Kapodistrian University of Athens, Medical School, Athens, Greece. The source(s) of support in the form of grants or industrial support This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Address correspondence to Stylianos Panopoulos, MD, PhD, Joint Rheumatology Program, Rheumatology Unit, 1st Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens, Μedical School General Hospital of Athens LAIKO. 17 Agiou Thoma str., 115 27 Athens, Greece.
Petros P. Sfikakis
First Department of Propaedeutic and Internal Medicine and Joint Rheumatology Program, National and Kapodistrian University of Athens, Medical School, Athens, Greece. The source(s) of support in the form of grants or industrial support This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Address correspondence to Stylianos Panopoulos, MD, PhD, Joint Rheumatology Program, Rheumatology Unit, 1st Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens, Μedical School General Hospital of Athens LAIKO. 17 Agiou Thoma str., 115 27 Athens, Greece.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Anti-IL-6 Therapy Effect for Refractory Joint and Skin Involvement in Systemic Sclerosis: A Real-world, Single Center Experience
Stylianos T. Panopoulos, Maria G. Tektonidou, Vasiliki-Kalliopi Bournia, Aikaterini Arida, Petros P. Sfikakis
The Journal of Rheumatology Aug 2021, jrheum.210273; DOI: 10.3899/jrheum.210273
Accepted manuscript
Anti-IL-6 Therapy Effect for Refractory Joint and Skin Involvement in Systemic Sclerosis: A Real-world, Single Center Experience
Stylianos T. Panopoulos, Maria G. Tektonidou, Vasiliki-Kalliopi Bournia, Aikaterini Arida, Petros P. Sfikakis
The Journal of Rheumatology Aug 2021, jrheum.210273; DOI: 10.3899/jrheum.210273